Unity Biotechnology

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$0
$1,902
$0
$0
Gross Profit
-221
-227
-308
EBITDA
-9,958
-7,872
-14,931
EBIT
-10,179
-8,099
-15,239
Net Income
-5,279
-5,790
-1,498
-15,289
Net Change In Cash
0
1,902
0
0
Free Cash Flow
-4,584
-5,183
-7,575
-7,125
Cash
7,584
7,430
19,803
7,876
Basic Shares
16,815
16,785
16,784
14,598

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$236
$4,784
$0
Gross Profit
-19,699
-1,944
1,904
-3,449
EBITDA
-37,283
-56,369
-57,548
-89,956
EBIT
-38,465
-58,549
-60,428
-93,405
Net Income
-39,860
-57,747
-60,039
-91,869
Net Change In Cash
0
236
4,784
0
Cost of Revenue
-20,719
-19,666
Free Cash Flow
-38,662
-51,125
-45,255
-78,979
Cash
19,803
12,736
32,905
17,807
Basic Shares
14,773
9,494
5,581
5,086

Earnings Calls

Quarter EPS
2024-06-30
-$0.31
2024-03-31
-$0.34
2023-12-31
-$0.28
2023-09-30
-$0.66